Study of vitamin D status of rheumatoid arthritis patients: Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR);Studio dello stato vitaminico D in pazienti affetti da artrite reumatoide: Razionale e disegno della rilevazione cross-sectional programmata dal gruppo SIR per lo studio dell'osteoporosi e delle malattie metaboliche dello scheletro

Reumatismo

Volumn 58, Issue 4, 2006, Pages 314-318

  Frediani, Bruno ^a   Rossini, M ^b   Adami, S ^b   Bianchi, G ^b   Di Munno, O ^b   Sinigaglia, L ^b   Antonelli, M ^b   Minisola, G ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b NONE

Author keywords

Immunity; Inflammation; Rheumatoid arthritis; Vitamin D

Indexed keywords

ALKALINE PHOSPHATASE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; BONE DENSITY CONSERVATION AGENT;

ARTICLE; BONE DENSITOMETRY; BONE TURNOVER; DISEASE ACTIVITY; DRUG EFFECT; DRUG MECHANISM; HUMAN; KIDNEY FAILURE; LIVER DISEASE; MEDICAL SOCIETY; METABOLIC DISORDER; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; RHEUMATOID ARTHRITIS; SEX RATIO; ADULT; AGED; BLOOD; CROSS-SECTIONAL STUDY; FEMALE; FEMUR; ITALY; LUMBAR VERTEBRA; MALE; METABOLIC BONE DISEASE; METABOLISM; MIDDLE AGED; RADIODENSITOMETRY; RADIOGRAPHY; RHEUMATOLOGY;

ADULT; AGED; ALKALINE PHOSPHATASE; ARTHRITIS, RHEUMATOID; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; FEMALE; FEMUR; HUMANS; ITALY; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; RHEUMATOLOGY; SOCIETIES, MEDICAL; VITAMIN D;

EID: 34247134535     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rico H, Revilla M, Alvarez de Buergo M, Villa LF. Serum osteocalcin and calcitropic hormones in a homogeneous group of patients with rheumatoid arthritis: its implication in the osteopenia of the disease. Clin Exp Rheumatol 1993; 11: 53-6.
2. Kroger H, Penttila IM, Alhava EM. Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol 1993; 22: 172-7.
3. Oelzner P, Lehmann G, Eidner T, Franke S, Muller A, Wolf G, et al. Hypercalcemia in rheumatoid arthritis: relationship with disease activity and bone metabolism. Rheumatol Int 2006; 26: 908-15.
4. Oelzner P, Muller A, Deschner F, Huller M, Abendroth K, Hein G, et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 1998; 63: 193-8.
5. Inaba M, Yukioka K, Furumitsu Y, Murano M, Goto H, Nishizawa Y et al. Positive correlation between leveles of IL-1 or IL-2 and 1,25(OH)2D/25-OH-D ratio in synovial fluid of patients with rheumatoid arthritis. Life Sci 1997; 61: 977-85.
6. Cutolo M, Sulli A, Otsa K, Laas K, Yprus M, Lehtme R, et al. Circannual rhythms of rheumatoid arthritis disease activity and vitamin D serum levels: south versus north europe. Ann Rheum Dis 2006; 65 (Suppl II): 93.
7. Kauppinen-Mäkelin R, Tahtela R, Loyttyniemi E, Karkkainen J, ValimakiMJ. A high prevalence of hypovitaminosis D in Finnish medical in- and outpatients. J Intern Med 2001; 249: 559-63.
8. Munger KLM, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62: 60-5.
9. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis. Arthritis & Rheumatism 2004; 50: 72-7.
10. Muller K, Kriegbaum NJ, Baslund B, Sorensen OH, Thymann M, Bentzen K. Vitamin D3 metabolism in patients with rheumatoid diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 1995; 14: 397-400.
11. Bang B, Asmussen K, Sorensen OH, Oxholm P. Reduced 25-dihydroxyvitamin D levels in primary Sjogren's syndrome. Correlations to disease manifestations. Scand J Rheumatol 1999; 28: 180-3.
12. Lange U, Jung O, Teichmann J, Neeck G. Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 2001; 12: 1031-5.
13. Lange U, Teichmann J, Strunk J, Muller-Ladner U, Schmidt KL. Association of 1.25 vitamin D3 deficienzy, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int. 2005; 16: 1999-2004.
14. Muller k, Bendtzen K. Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differetial effects on CD45RA+ and CD45RO+ cells. Autoimmunity 1992; 14: 37-43.
15. Kitamura A. Study of the effects of a new vitamin D3 derivative on type II collagen-induced arthritis in an experimental rat model of rheumatoid arthritis. Nippon Seikeigeka Gakkai Zasshi 1994; 68.
16. Tsuji M, Fujii K, Nakano T, Nishii Y. 1 alpha-hydroxyvitamin D3 inhibits type II collagen-induced arthritis in rats. FEBS Lett 1994; 337: 248-50.
17. Larsson P, Mattsson L, Klareskog L, Johnsson C. A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia.Clin Exp Immunol 1998; 114: 277-83.
18. Tetlow LC, Woolley DE. The effects of 1 alpha, 25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion. Arthitis Res 1991; 1: 63-70.
19. Hein G, Oelzner P. Vitamin D metabolites in rheumatoid arthritis: findings- hypoteses-consequences. Z Rheumatol 2000; 59 Suppl 1: 28-32.
20. Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M. Regulation of 25- hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha 25-dihydroxyvitamin D3 by human dendritic cells. Blood 2003; 102: 3314-6.
21. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003; 17: 2386-92.
22. Cantorna MT, Hayes CE, DeLuca HF. 1,25-dihydroxyvitamin D3 is a positive regulator for the two antiencephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol 1998; 160: 5314-9.
23. Cantorna MT, Humpal-Winter J, DeLuca HF. In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihidroxyvitamin D(3). Arch Biochem Biophys 2000; 377: 135-8.
24. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis: resuls from Iowa Women's Health Study. Arthritis Rheum 2004; 50: 72-7.
25. Hayes CE, Nashold FE, Spach KM. The immunological function of the vitamin D endocrine system. Cell Mol Biol 2003; 49: 277-300.